In addition, fluorescence endoscopy is gaining increasing interest and could foster the clinical use of fluorescent contrast agents37; for example, in the evaluation of inflammatory bowel disease, which is known to exhibit a very high local expression of S100A8/S100A9 (calprotectin)38. This evidence concerns the gene S100A8 and inflammatory bowel disease.